# Effect of Liraglutide on Vascular Inflammation in Type-2 Diabetes

> **NCT03449654** · PHASE4 · COMPLETED · sponsor: **Steno Diabetes Center Copenhagen** · enrollment: 102 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Liraglutide
- **DRUG:** Placebo (for liraglutide)

## Key facts

- **NCT ID:** NCT03449654
- **Lead sponsor:** Steno Diabetes Center Copenhagen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-26
- **Primary completion:** 2019-08-16
- **Final completion:** 2019-08-16
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2020-06-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03449654

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03449654, "Effect of Liraglutide on Vascular Inflammation in Type-2 Diabetes". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03449654. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*